The effect of imatinib and nilotinib on blood calcium and blood potassium levels in chronic myeloid leukemia patient: a literature review
Imatinib and nilotinib are first-line treatments for chronic myeloid leukemia (CML) patients, which act specifically against target cells. However, these drugs may cause side effects, such as electrolyte disturbances. This literature review aimed to provide a comparison of the effects of imatinib a...
Guardado en:
Autores principales: | Muhammad Darwin Prenggono, Alfi Yasmina, Misna Ariyah, Tenri Ashari Wanahari, Nuvita Hasrianti |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
PAGEPress Publications
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4a95a91f1fce4f65843fdb59d347e853 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Update on the management of Philadelphia chromosome positive chronic myelogenous leukemia: role of nilotinib
por: Emole J, et al.
Publicado: (2016) -
A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer
por: Archibald M, et al.
Publicado: (2016) -
EARLY MOLECULAR RESPONSE WITH IMATINIB THERAPY IN CHRONIC MYELOID LEUKEMIA AND ITS ASSOCIATION WITH BASELINE WHITE BLOOD CELL COUNT AND SPLEEN SIZE
por: Abdul Ali Wajid, et al.
Publicado: (2018) -
A Retrospective Cohort Study of Upfront Nilotinib in Chronic Myeloid Leukemia: A Single-Center Experience
por: Reema Singh, et al.
Publicado: (2021) -
NEOADYUVANCIA CON IMATINIB EN EL MANEJO DE GIST GIGANTE DEL TABIQUE RECTOVAGINAL
por: Bannura C,Guillermo, et al.
Publicado: (2014)